IQVIA Holdings Inc Gets a Hold Rating from Piper Jaffray

By Ryan Adsit

Piper Jaffray analyst Sean Wieland reiterated a Hold rating on IQVIA Holdings Inc (NYSE: IQV) today and set a price target of $103. The company’s shares opened today at $105.51, close to its 52-week high of $110.67.

According to, Wieland is a 5-star analyst with an average return of 21.9% and a 63.4% success rate. Wieland covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, Medidata Solutions, and Quality Systems.

IQVIA Holdings Inc has an analyst consensus of Hold, with a price target consensus of $105.80.

Based on the recent corporate insider activity of 63 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

IQVIA Holdings, Inc. is a biotechnology company, which engages in healthcare development in the provision of professional services, information technology, and partnering solutions to the pharmaceutical services and healthcare industries. The company was founded by Dennis Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.